Neuromuscular Disorders
Volume 17, Issue 7 , Pages 569-574 , July 2007

Cytoplasmic γ-actin expression in diverse animal models of muscular dystrophy

  • Laurin M. Hanft

      Affiliations

    • Department of Physiology, University of Wisconsin, Madison, WI, United States
    • ,
  • Daniel J. Bogan

      Affiliations

    • College of Veterinary Medicine and Dalton Cardiovascular Research Center, University of Missouri, Columbia, MO, United States
    • ,
  • Ulrike Mayer

      Affiliations

    • Wellcome Trust Centre for Cell-Matrix Research, University of Manchester, Manchester, UK
    • ,
  • Stephen J. Kaufman

      Affiliations

    • Department of Cell and Developmental Biology, University of Illinois, Urbana, IL, United States
    • ,
  • Joe N. Kornegay

      Affiliations

    • College of Veterinary Medicine and Dalton Cardiovascular Research Center, University of Missouri, Columbia, MO, United States
    • ,
  • James M. Ervasti

      Affiliations

    • Department of Physiology, University of Wisconsin, Madison, WI, United States
    • Corresponding Author InformationCorresponding author. Address: Department of Biochemistry, Molecular Biology & Biophysics, University of Minnesota, 6-155 Jackson Hall, 321 Church Street SE, Minneapolis, MN 55455, United States. Tel.: +1 612 626 6517; fax: +1 612 625 2163.

Received 19 December 2006 ,Revised 26 February 2007 ,Accepted 5 March 2007.

References 

  1. O’Brien KF, Kunkel LM. Dystrophin and muscular dystrophy: past, present, and future. Mol Genet Metab. 2001;74:75–88
  2. Cohn RD, Campbell KP. Molecular basis of muscular dystrophies. Muscle Nerve. 2000;23:1456–1471
  3. Blake DJ, Weir A, Newey SE, Davies KE. Function and genetics of dystrophin and dystrophin-related proteins in muscle. Physiol Rev. 2002;82:291–329
  4. Rybakova IN, Patel JR, Ervasti JM. The dystrophin complex forms a mechanically strong link between the sarcolemma and costameric actin. J Cell Biol. 2000;150:1209–1214
  5. Rybakova IN, Patel JR, Davies KE, Yurchenco PD, Ervasti JM. Utrophin binds laterally along actin filaments and can couple costameric actin with the sarcolemma when overexpressed in dystrophin-deficient muscle. Mol Biol Cell. 2002;13:1512–1521
  6. Hanft LM, Rybakova IN, Patel JR, Rafael-Fortney JA, Ervasti JM. Cytoplasmic γ-actin contributes to a compensatory remodeling response in dystrophin-deficient muscle. Proc Natl Acad Sci USA. 2006;103:5385–5390
  7. Liu JM, Okamura CS, Bogan DJ, Bogan JR, Childers MK, Kornegay JN. Effects of prednisone in canine muscular dystrophy. Muscle Nerve. 2004;30:767–773
  8. Duclos F, Straub V, Moore SA, et al. Progressive muscular dystrophy in α-sarcoglycan-deficient mice. J Cell Biol. 1998;142:1461–1471
  9. Durbeej M, Cohn RD, Hrstka RF, et al. Disruption of the β-sarcoglycan gene reveals pathogenetic complexity of limb-girdle muscular dystrophy type 2E. Mol Cell. 2000;5:141–151
  10. Grady RM, Grange RW, Lau KS, et al. Role for α-dystrobrevin in the pathogenesis of dystrophin-dependent muscular dystrophies. Nat Cell Biol. 1999;1:215–220
  11. Mayer U, Saher G, Fässler R, et al. Absence of integrin α7 causes a novel form of muscular dystrophy. Nat Genet. 1997;17:318–323
  12. Burkin DJ, Wallace GQ, Nicol KJ, Kaufman DJ, Kaufman SJ. Enhanced expression of the alpha 7 beta 1 integrin reduces muscular dystrophy and restores viability in dystrophic mice. J Cell Biol. 2001;152:1207–1218
  13. Bonifati MD, Ruzza G, Bonometto P, et al. A multicenter, double-blind, randomized trial of deflazacort versus prednisone in Duchenne muscular dystrophy. Muscle Nerve. 2000;23:1344–1347
  14. Carter GT, McDonald CM. Preserving function in Duchenne dystrophy with long-term pulse prednisone therapy. Am J Phys Med Rehabil. 2000;79:455–458
  15. Wong BL, Christopher C. Corticosteroids in Duchenne muscular dystrophy: a reappraisal. J Child Neurol. 2002;17:183–190
  16. Ozawa E, Mizuno Y, Hagiwara Y, Sasaoka T, Yoshida M. Molecular and cell biology of the sarcoglycan complex. Muscle Nerve. 2005;32:563–576
  17. Hack AA, Lam MY, Cordier L, et al. Differential requirement for individual sarcoglycans and dystrophin in the assembly and function of the dystrophin–glycoprotein complex. J Cell Sci. 2000;113(Pt 14):2535–2544
  18. Mizuno Y, Thompson TG, Guyon JR, et al. Desmuslin, an intermediate filament protein that interacts with alpha-dystrobrevin and desmin. Proc Natl Acad Sci USA. 2001;98:6156–6161
  19. Newey SE, Howman EV, Ponting CP, et al. Syncoilin, a novel member of the intermediate filament superfamily that interacts with alpha-dystrobrevin in skeletal muscle. J Biol Chem. 2001;276:6645–6655
  20. Poon E, Howman EV, Newey SE, Davies KE. Association of syncoilin and desmin: linking intermediate filament proteins to the dystrophin-associated protein complex. J Biol Chem. 2002;277:3433–3439
  21. Bellin RM, Sernett SW, Becker B, Ip W, Huiatt TW, Robson RM. Molecular characteristics and interactions of the intermediate filament protein synemin. Interactions with alpha-actinin may anchor synemin-containing heterofilaments. J Biol Chem. 1999;274:29493–29499
  22. Bellin RM, Huiatt TW, Critchley DR, Robson RM. Synemin may function to directly link muscle cell intermediate filaments to both myofibrillar Z-lines and costameres. J Biol Chem. 2001;276:32330–32337
  23. Sunada Y, Bernier SM, Kozak CA, Yamada Y, Campbell KP. Deficiency of merosin in dystrophic dy mice and genetic linkage of laminin M chain gene to dy locus. J Biol Chem. 1994;269:13729–13732
  24. Ohlendieck K, Campbell KP. Dystrophin-associated proteins are greatly reduced in skeletal muscle from mdx mice. J Cell Biol. 1991;115:1685–1694
  25. Straub V, Rafael JA, Chamberlain JS, Campbell KP. Animal models for muscular dystrophy show different patterns of sarcolemmal disruption. J Cell Biol. 1997;139:375–385
  26. Jin Y, Murakami N, Saito Y, Goto Y, Koishi K, Nonaka I. Expression of MyoD and myogenin in dystrophic mice, mdx and dy, during regeneration. Acta Neuropathol (Berl). 2000;99:619–627
  27. Allikian MJ, Hack AA, Mewborn S, Mayer U, McNally EM. Genetic compensation for sarcoglycan loss by integrin α7β1 in muscle. J Cell Sci. 2004;117:3821–3830
  28. Guo C, Willem M, Werner A, et al. Absence of α7 integrin in dystrophin-deficient mice causes a myopathy similar to Duchenne muscular dystrophy. Hum Mol Genet. 2006;15:989–998
  29. Rooney JE, Welser JV, Dechert MA, Flintoff-Dye NL, Kaufman SJ, Burkin DJ. Severe muscular dystrophy in mice that lack dystrophin and α7 integrin. J Cell Sci. 2006;119:2185–2195
  30. Grady RM, Teng HB, Nichol MC, Cunningham JC, Wilkinson RS, Sanes JR. Skeletal and cardiac myopathies in mice lacking utrophin and dystrophin: a model for Duchenne muscular dystrophy. Cell. 1997;90:729–738
  31. Deconinck AE, Rafael JA, Skinner JA, et al. Utrophin–dystrophin-deficient mice as a model for Duchenne muscular dystrophy. Cell. 1997;90:717–727
  32. Thompson TG, Chan YM, Hack AA, et al. Filamin 2 (FLN2): a muscle-specific sarcoglycan interacting protein. J Cell Biol. 2000;148:115–126
  33. Schroder R, Mundegar RR, Treusch M, et al. Altered distribution of plectin/HD1 in dystrophinopathies. Eur J Cell Biol. 1997;74:165–171
  34. Law DJ, Allen DL, Tidball JG. Talin, vinculin and DRP (utrophin) concentrations are increased at mdx myotendinous junctions following onset of necrosis. J Cell Sci. 1994;107:1477–1483
  35. Vachon PH, Xu H, Liu L, et al. Integrins (α7β1) in muscle function and survival – Disrupted expression in merosin-deficient congenital muscular dystrophy. J Clin Invest. 1997;100:1870–1881
  36. Hodges BL, Hayashi YK, Nonaka I, Wang W, Arahata K, Kaufman SJ. Altered expression of the α7β1 integrin in human and murine muscular dystrophies. J Cell Sci. 1997;110:2873–2881
  37. Matsumura K, Ervasti JM, Ohlendieck K, Kahl SD, Campbell KP. Association of dystrophin-related protein with dystrophin-associated proteins in mdx mouse muscle. Nature. 1992;360:588–591
  38. Porter JD, Rafael JA, Ragusa RJ, Brueckner JK, Trickett JI, Davies KE. The sparing of extraocular muscle in dystrophinopathy is lost in mice lacking utrophin and dystrophin. J Cell Sci. 1998;111:1801–1811
  39. Wilson LA, Cooper BJ, Dux L, Dubowitz V, Sewry CA. Expression of utrophin (dystrophin-related protein) during regeneration and maturation of skeletal muscle in canine X-linked muscular dystrophy. Neuropathol Appl Neurobiol. 1994;20:359–367
  40. Schatzberg SJ, Olby NJ, Breen M, et al. Molecular analysis of a spontaneous dystrophin ‘knockout’ dog. Neuromuscul Disord. 1999;9:289–295
  41. Petrof BJ, Shrager JB, Stedman HH, Kelly AM, Sweeney HL. Dystrophin protects the sarcolemma from stresses developed during muscle contraction. Proc Natl Acad Sci USA. 1993;90:3710–3714

PII: S0960-8966(07)00085-5

doi: 10.1016/j.nmd.2007.03.004

Neuromuscular Disorders
Volume 17, Issue 7 , Pages 569-574 , July 2007

Article Tools

* Image Usage & Resolution